Literature DB >> 25855921

Primary aldosteronism with concurrent primary hyperparathyroidism: clinical case load in a single centre.

A Concistré1, L Petramala, L Zinnamosca, A Settevendemmie, F Corpaci, C Marinelli, G F Tonnarini, G D'Ermo, G De Toma, C Letizia.   

Abstract

OBJECTIVE: Primary aldosteronism (PA) represents the main cause of endocrine secondary arterial hypertension in which aldosterone production is inappropriately elevated. Primary hyperparathyroidism (PHPT) is an endocrine disease characterized by hypercalcemia due to overproduction of parathyroid hormone (PTH). Although these two endocrine pathologies are secondary to hypertension in middle aged population, the occurrence of the PHPT in PA patients has rarely reported in the literature. The aim of the study was to describe some PA patients with concurrent PHPT, referred in a tertiary center of arterial hypertension. PATIENTS: We performed a retrospective study. In particular, the registry of 306 patients with PA seen in our center since 2004 was examined and revealed 8 patients (2.6%) with concurrent PHPT.
CONCLUSIONS: There are several possible explanations for the association of these two endocrine disorders, including the combination was a random finding that PA inheres PHPT or vice versa.

Entities:  

Mesh:

Year:  2015        PMID: 25855921

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  Double hit! A unique case of resistant hypertension.

Authors:  Kristen Elizabeth DeCarlo; Nidhi Agrawal
Journal:  BMJ Case Rep       Date:  2017-12-22

2.  Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis.

Authors:  Shaomin Shi; Chunyan Lu; Haoming Tian; Yan Ren; Tao Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-25       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.